Northwestern Mutual Wealth Management
AMLX icon

Northwestern Mutual Wealth Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-300
Closed -$4K – 3154
2022
Q1 		$4K Buy
+300
New +$6.78K ﹤0.01% 2775

Other funds holding AMLX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northwestern Mutual Wealth Management's AMLX Position: Q2 2022 in Review

Northwestern Mutual Wealth Management sold out of Amylyx Pharmaceuticals (AMLX) in Q2 2022, closing a stake of 300 shares — an estimated $4K sold.

Northwestern Mutual Wealth Management first reported a position in AMLX in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 78 funds tracked by Wall St. Rank hold AMLX as of Q2 2022.

  • Northwestern Mutual Wealth Management reported no remaining Amylyx Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 300 Amylyx Pharmaceuticals shares in Q2 2022, an estimated $4K.
  • Northwestern Mutual Wealth Management first reported a position in Amylyx Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Amylyx Pharmaceuticals position peaked at $4K in Q1 2022.
  • 78 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2022.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2022, filed 4 Aug 2022.